Colistimethate
NDC 63323-393, COLISTIMETHATE SODIUM, injection, powder, lyophilized, for solution, from Fresenius Kabi USA, LLC.
- Product NDC
- 63323-393
- Status
- Listed
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAMUSCULAR, INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA065364
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63323-393 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- COLISTIMETHATE SODIUM150 mg/2mL
Pharmacologic classes
Polymyxin-class Antibacterial [EPC]; Polymyxins [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63323-393-06 | 63323039306 | 1 VIAL in 1 BOX (63323-393-06) / 2 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ab241809-0d2f-44ba-829c-26be67ee623fMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=63323-393NADAC price for package 63323039306
GET /v1/drugs/nadac/63323039306
Use it
Look up 63323-393 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63323-393 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63323-393. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.